The case involves an application filed under Section 33(2) of the Insolvency and Bankruptcy Code, 2016 by Mr. Girish Siriram Juneja, the Resolution Professional (RP) of Aegis Medicines Private Limited, seeking a liquidation order. The Committee of Creditors (CoC) had resolved in its 12th meeting on 15.12.2023 to pursue liquidation. The Corporate Insolvency Resolution Process (CIRP) was initiated, and Mr. Juneja was appointed as the Interim Resolution Professional (IRP). Public announcements were made to invite claims from creditors. The CoC was formed based on the claims received. The RP invited Expression of Interest (EoI) and received five EoIs. The CoC deliberated on a resolution plan but ultimately rejected it with 100% votes. Subsequently, the CoC approved the

The case involves an application filed under Section 33(2) of the Insolvency and Bankruptcy Code, 2016 by Mr. Girish Siriram Juneja, the Resolution Professional (RP) of Aegis Medicines Private Limited, seeking a liquidation order. The Committee of Creditors (CoC) had resolved in its 12th meeting on 15.12.2023 to pursue liquidation. The Corporate Insolvency Resolution Process (CIRP) was initiated, and Mr. Juneja was appointed as the Interim Resolution Professional (IRP). Public announcements were made to invite claims from creditors. The CoC was formed based on the claims received. The RP invited Expression of Interest (EoI) and received five EoIs. The CoC deliberated on a resolution plan but ultimately rejected it with 100% votes. Subsequently, the CoC approved the